Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
US |
|
Banimmo SA
XBRU:BANI
|
BE |
|
Decibel Cannabis Company Inc
OTC:DBCCD
|
CA |
|
Q
|
Qualcomm Inc
BMV:QCOM
|
US |
|
P
|
Performance Food Group Co
F:P5F
|
US |
|
A
|
Antofagasta PLC
F:FG1
|
UK |
|
Vonovia SE
F:VNAA
|
DE |
|
P
|
PlasCred Circular Innovations Inc
CNSX:PLAS
|
CA |
|
A
|
Amphenol Corp
DUS:XPH
|
US |
|
4C Group AB
STO:4C
|
SE |
|
Brunswick Corp
NYSE:BC
|
US |
|
W.p. Carey Inc
NYSE:WPC
|
US |
|
G
|
Generation Mining Ltd
F:9GN
|
CA |
|
Cannabis Suisse Corp
OTC:CSUI
|
US |
|
H
|
HLB Pep Co Ltd
KOSDAQ:196300
|
KR |
|
W
|
W.p. Carey Inc
SWB:WPY
|
US |
|
W
|
W.p. Carey Inc
LSE:0LS8
|
US |
|
B
|
Brunswick Corp
XMUN:BWI
|
US |
|
B
|
Brunswick Corp
F:BWI
|
US |
|
W
|
W.p. Carey Inc
F:WPY
|
US |
Bankruptcy Probability
Arrowhead Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arrowhead Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
8.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
258.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
216.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
103.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arrowhead Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arrowhead Pharmaceuticals Inc has total debt of 1.2B USD. This includes both short-term (0 USD) and long-term (1.2B USD) debt.
You can find a full breakdown on its Balance Sheet.
